Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Change in Receivables (2024 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Change in Receivables for 2 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 38.52% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 73.64% year-over-year, with the annual reading at $3.4 million for FY2025, 73.64% down from the prior year.
  • Change in Receivables for Q4 2025 was $7.8 million at Nuvation Bio, up from $5.6 million in the prior quarter.
  • The five-year high for Change in Receivables was $12.6 million in Q4 2024, with the low at -$12.3 million in Q1 2025.